For a 67-year-old female with type 1 diabetes, weight 61 kg, normal renal function, taking olanzapine (Zyprexa), buspirone (Buspar), hydroxyzine (Atarax), quetiapine (Seroquel), sertraline (Zoloft), and trazodone, currently on insulin glargine (Lantus) 8 U daily with an insulin‑to‑carbohydrate ratio of 1 U per 12 g carbs and an insulin sensitivity factor of 1 U per 60 mg/dL, and experiencing hyperglycemia (glucose 314–354 mg/dL) but prone to hypoglycemia if aggressive, what should her insulin glargine dose, insulin‑to‑carbohydrate ratio, and insulin sensitivity factor be?

Insulin Dose Adjustment for Type 1 Diabetes with Persistent Hyperglycemia

Given this patient's persistent hyperglycemia (glucose 268-354 mg/dL) despite current therapy, increase Lantus to 12 units daily, tighten the ICR to 1:10g, and strengthen the ISF to 1:50 mg/dL, while monitoring closely for hypoglycemia given her history of hypoglycemia-prone episodes.

Critical Context: Antipsychotic-Induced Hyperglycemia

This patient is on olanzapine (Zyprexa) and quetiapine (Seroquel), both of which are among the highest-risk antipsychotics for inducing hyperglycemia and insulin resistance 1, 2, 3, 4. Olanzapine in particular can cause severe hyperglycemia through direct pancreatic beta-cell dysfunction and peripheral insulin resistance, independent of weight gain 2, 4. This is likely a major contributor to her poor glycemic control and must be factored into insulin dosing decisions.

Recommended Insulin Adjustments

Basal Insulin (Lantus)

Current: 8 units daily
Recommended: 12 units daily

Rationale:

• At 61 kg with type 1 diabetes and severe hyperglycemia (>300 mg/dL), guideline-based dosing suggests 0.3-0.5 U/kg total daily dose 5, 6
• This calculates to 18-30 units total daily insulin
• Her current total daily insulin is approximately 12 units (8 basal + ~4 units prandial for 48g carbs)
• Increase basal by 50% (from 8 to 12 units) as a conservative first step given hypoglycemia risk 6
• The persistent overnight hyperglycemia (354 at 2100,268 at 0200) indicates inadequate basal coverage

Insulin-to-Carbohydrate Ratio (ICR)

Current: 1:12g
Recommended: 1:10g

Rationale:

• Post-lunch glucose rose from 314 to 324 despite 48g carbs and ~4 units of insulin
• This minimal response indicates the current 1:12 ratio is too weak
• Tightening to 1:10 increases mealtime insulin by 20%, providing 4.8 units for the same meal
• This is a measured adjustment that reduces hypoglycemia risk while addressing postprandial hyperglycemia

Insulin Sensitivity Factor (ISF)

Current: 1:60 mg/dL (>180), 1:100 mg/dL (bedtime/0200 if >300)
Recommended: 1:50 mg/dL uniformly

Rationale:

• Current correction doses are insufficient—glucose remained 268-354 despite multiple correction opportunities
• The dual ISF system (60 vs 100) is unnecessarily complex and the weaker bedtime factor (1:100) leaves overnight hyperglycemia undertreated
• A uniform 1:50 ISF provides more aggressive correction while remaining safer than the "usual" column recommendation of 1:40-50 for most patients 5
• For this hypoglycemia-prone patient, use the "insulin-sensitive" correction scale from guidelines, which recommends 2-4 units for glucose 141-220 mg/dL 5

Specific Dosing Protocol

Morning (Fasting)

• Lantus: 12 units (increased from 8)
• Check fasting glucose; if >150 mg/dL, give correction: (glucose - 100) ÷ 50

Before Each Meal

• Prandial insulin: carbs ÷ 10 (changed from ÷12)
• Correction if glucose >140 mg/dL: (glucose - 100) ÷ 50
• Combined dose = carb coverage + correction

Bedtime

• If glucose >140 mg/dL: (glucose - 100) ÷ 50
• No separate ISF for bedtime—use same formula

0200 Check

• If glucose >180 mg/dL: (glucose - 120) ÷ 50 (slightly higher target overnight to prevent nocturnal hypoglycemia)

Critical Safety Considerations

Hypoglycemia Prevention

Given her documented hypoglycemia tendency, implement these safeguards:

1. Titrate gradually: Increase Lantus by only 2 units every 3 days if fasting glucose remains >150 mg/dL 7
2. Lower correction threshold: Only correct if glucose >140 mg/dL (not the typical >180 mg/dL) to avoid stacking insulin
3. Hold prandial insulin: If pre-meal glucose <100 mg/dL, reduce carb coverage by 50%
4. Elderly considerations: At age 67 with normal renal function (GFR 81), she doesn't require the most conservative dosing (0.2-0.3 U/kg) reserved for those >70 with GFR <60 5, but caution is still warranted

Monitoring Requirements

• Check fasting glucose daily for 1 week after Lantus adjustment
• Check pre-meal and 2-hour post-meal glucose for 3 days to assess ICR
• If any glucose <70 mg/dL, reduce the corresponding insulin by 10-20% 7
• Recheck in 1 week; if fasting glucose consistently >150 mg/dL, increase Lantus by another 2 units

Addressing the Antipsychotic Problem

The elephant in the room: Olanzapine and quetiapine are directly sabotaging glycemic control 1, 2, 3, 4. While insulin adjustment is necessary, strongly consider psychiatric consultation to discuss:

• Switching to lower-risk antipsychotics (aripiprazole, ziprasidone) 3
• Dose reduction if clinically feasible
• Adding metformin if not contraindicated (though less effective in type 1 diabetes)

The combination of olanzapine + quetiapine creates a "double hit" of diabetogenic effects that may require insulin doses 30-50% higher than otherwise needed 2, 4.

Why Not More Aggressive?

The guidelines support basal-bolus regimens with 50% of total daily dose as basal 5, 6, which would suggest 9-15 units basal if targeting 18-30 units total. However:

• Her hypoglycemia history takes precedence over achieving perfect glucose targets 6
• The 2021 Lancet guidelines explicitly state that older patients (>65 years) warrant lower initial doses (0.3 U/kg) to minimize hypoglycemia risk 6
• Incremental titration is safer than aggressive upfront dosing in hypoglycemia-prone patients 7

Expected Outcomes

With these adjustments:

• Fasting glucose should decrease to 120-150 mg/dL within 3-5 days
• Post-meal glucose should improve to 150-200 mg/dL
• If glucose remains >200 mg/dL after 1 week, further titration is needed
• Accept glucose targets of 100-180 mg/dL rather than tight control (<140 mg/dL) given hypoglycemia risk 6, 8

5, 6, 5, 6, 7, 1, 2, 3, 4